Should we STOP angiotensin converting enzyme inhibitors/angiotensin receptor blockers in advanced kidney disease?
A Ahmed, T Jorna, S Bhandari - Nephron, 2016 - karger.com
Chronic kidney disease (CKD) is a worldwide public health problem associated with a high
prevalence of cardiovascular disease (CVD) and impaired quality of life. Previous research …
prevalence of cardiovascular disease (CVD) and impaired quality of life. Previous research …
Controlled release of metformin from chitosan–based nanocomposite films containing mesoporous MCM-41 nanoparticles as novel drug delivery systems
Z Shariatinia, Z Zahraee - Journal of colloid and interface science, 2017 - Elsevier
Biocompatible nanocomposite films based on blended chitosan and poly (ethylene glycol)-
block-poly (propylene glycol)-block-poly (ethylene glycol)(BP) polymers containing …
block-poly (propylene glycol)-block-poly (ethylene glycol)(BP) polymers containing …
The inhibitory potential of Montmorency tart cherry on key enzymes relevant to type 2 diabetes and cardiovascular disease
A Kirakosyan, E Gutierrez, BR Solano, EM Seymour… - Food Chemistry, 2018 - Elsevier
The inhibitory potential of Montmorency tart cherry on glycemia regulation and other
enzymes relevant to inflammation were evaluated. Tart cherry has superior inhibitory …
enzymes relevant to inflammation were evaluated. Tart cherry has superior inhibitory …
Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus …
SY Choi, BG Choi, SW Rha, JK Byun… - International Journal of …, 2017 - Elsevier
Abstract Background Diabetes Mellitus (DM) is an important factor of adverse cardiovascular
events in acute ST-segment elevation myocardial infarction (STEMI) patients. Renin …
events in acute ST-segment elevation myocardial infarction (STEMI) patients. Renin …
High glucose instigates tubulointerstitial injury by stimulating hetero-dimerization of adiponectin and angiotensin II receptors
D Zha, H Cheng, W Li, Y Wu, X Li, L Zhang… - Biochemical and …, 2017 - Elsevier
Abnormal expression and dysfunction of adiponectin and the cognate receptors are involved
in diabetes and diabetic kidney disease (DKD), whereas angiotensin receptor blockers …
in diabetes and diabetic kidney disease (DKD), whereas angiotensin receptor blockers …
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients
E Movilli, C Camerini, P Gaggia, R Zubani… - American Journal of …, 2018 - karger.com
Background: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor
blockers (ARB) are increasingly used in uremic patients (pts). However, their effect on serum …
blockers (ARB) are increasingly used in uremic patients (pts). However, their effect on serum …
Effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on total and cardiovascular mortality and morbidity in primary prevention …
E Oger, S Kerbrat, E Nowak, F Paillard… - The Journal of …, 2022 - Wiley Online Library
Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …
Statin use and the risk for incident diabetes mellitus in patients with acute coronary syndrome after percutaneous coronary intervention: a population-based …
ZF Lin, CY Wang, LJ Shen, FY Hsiao, FLL Wu - Canadian journal of …, 2016 - Elsevier
Objectives The purpose of this study was to examine the association between statin use by
individuals and the risk for incident diabetes mellitus in patients with acute coronary …
individuals and the risk for incident diabetes mellitus in patients with acute coronary …